[White Paper] Impact...
21st May 2020 Content supplied by: Rapid Micro Biosystems
Rapid Micro Biosystems Announces Global Expansion to Support Pharma Manufacturing
Rapid Micro Biosystems recently received $120 million in funding to help the company meet a growing global demand for their automated microbial detection platform Growth Direct.™
Growth Direct is the first, digitized platform for three critical QC applications: environmental monitoring, water testing, and bioburden testing. With Growth Direct, labs can eliminate 60% of the steps of manual methods and achieve:
- Data integrity
- Operational efficiencies
- Higher quality products for improved patient outcomes
- Compliance with the requirements of 21 CFR PART 11
See the system action and discover how digitizing your lab can accelerate time to results and prevent human error in the QC lab.
Date Published: 21st May 2020
Source article link: https://www.rapidmicrobio.com/blog/rapid-microbiology-testing
[White Paper] Impact of Data